Protective Effects of EPI-743 on Noise-Induced Hearing Loss

Noise-induced Hearing Loss Clinical Trial

Official title:
A Phase 2A Randomized, Placebo Controlled, Double Blind Study of the Protective Effects of EPI-743 (VincerinoneTM) on Noise-Induced Hearing Loss

Status Completed

Clinical Trial Summary

If effective, administration of EPI-743 should have protective effects against temporary noise-induced hearing loss.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02257983
Study type	Interventional
Source	Edison Pharmaceuticals Inc
Contact
Status	Completed
Phase	Phase 2
Start date	October 31, 2014
Completion date	February 29, 2016

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01345474` - Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)	Phase 3
Terminated	`NCT02903355` - Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)	Phase 3
Withdrawn	`NCT02049073` - Prevention of Noise-induced Hearing Loss	Phase 1/Phase 2
Completed	`NCT02259595` - Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC	Phase 1
Completed	`NCT00808470` - Micronutrients to Prevent Noise-induced Hearing Loss	Phase 2
Recruiting	`NCT01727492` - Prevention of Noise-induced Damage by Use of Antioxidants	N/A
Completed	`NCT01454895` - Test of a Web-based Intervention to Promote Hearing Protector Use	N/A
Completed	`NCT02472821` - Test of Hearing Health Education Programs for Farm and Rural Youth	N/A